Thomas Templeman - 31 Mar 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Reporting relationship
Chief Technology Officer
Issuer ticker
CNTA
Reported as of
31 Mar 2023
Net transaction value
-$16,002
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Apr 2023, 17:04:29 UTC
Prior SEC filing
03 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gregory Weinhoff, attorney-in-fact

Key filing fact

Thomas Templeman filed Form 4 for Centessa Pharmaceuticals plc (CNTA) on 04 Apr 2023.

Key facts

  • This page summarizes Thomas Templeman's Form 4 filing for Centessa Pharmaceuticals plc (CNTA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Apr 2023, 17:04.

Change

  • Previous filing in this sequence was filed on 03 Feb 2023.
  • Current net transaction value: -$16,002.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNTA transaction

Ordinary Shares

Tax liability

Transaction value
$16,002
Shares
-4,103
Change %
-2.1%
Price
$3.90
Shares after
188,244
Date
31 Mar 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .